The Mag

Big business Bioprocessing

The expansion of global biomanufacturing capacity has been the dominant topic not only since the approval of the most successful biotech drug of all time, Pfizer/BioNTech's mRNA-based COVID-19 vaccine Comirnaty.

In this issue:

  • Mastering the data revolution of clinical trials
  • Lead optimisation – the sequence is the key
  • Automating patient-derived cell production – Interview with Nabiha Sakalyen, CEO & co-founder of Cellino Biotech Inc.
  • A new purification workflow
  • RTSM benefits: configuration vs. customisation

Marketing Contacts:

Andreas Macht
Tel: +49-30-264921-54

Oliver Schnell
Tel: +49-30-264921-45

Editorial Contact:

Thomas Gabrielczyk
Tel: +49-30-264921-50